Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
about
Microparticles as Biomarkers of Blood Coagulation in CancerVenous thromboembolism (VTE) and glioblastoma.Brain neoplasms and coagulation-lessons from heterogeneity.Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.Venous thrombosis and cancer: from mouse models to clinical trials.Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model.Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayAbsence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originCancer-associated pathways and biomarkers of venous thrombosis.Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression.Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.Mutant IDH1 and thrombosis in gliomas.Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype.Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.Cancer-associated thrombosis: The search for the holy grail continues
P2860
Q26783691-17E3DD2E-BF91-4F89-B0E0-6E1699B1D163Q33422929-A0AC891B-7216-462C-9037-8A4A7F92BD56Q34463432-9C6DCAF3-ED2D-4546-961E-676DE8D13B1EQ36470049-A07C53CA-4C70-407D-AE07-5B160D6FB0D8Q36636558-DCA7A365-4860-4E71-AFB4-A7358361F92BQ37001337-BAC5F9C1-8A4E-4D77-9EFE-34599C5B94A4Q37169096-1D1C7664-4CAC-45EB-875A-90D1C2505AD4Q38379177-3C512920-94E6-451A-A7E1-1249080F1074Q38496748-5F7F832A-722B-477E-BC62-82C56FB7023BQ38642557-0DBE8EFD-0E92-4C48-9C9A-9024F949740AQ38801117-FB5227D6-FB5F-46F7-8A4C-B7078F18D830Q39028469-8A9EC7BA-D44D-404B-8D6D-D9E5E03A36B0Q39355644-B094F59A-5B5E-4BBB-AE6C-9F6148DF8708Q44444427-A00BC46D-15CF-4815-91C8-E135D623C61FQ47192469-DC36C08D-9DE3-4F2A-A820-1A517FB8E3CAQ55457269-53691508-D230-4D37-829D-1F0FCFAA23B8Q57824763-78050E86-10DE-4996-A0D6-376316E81548
P2860
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@en
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@nl
type
label
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@en
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@nl
prefLabel
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@en
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@nl
P2093
P50
P1433
P1476
Intratumoral tissue factor exp ...... olism in brain tumor patients.
@en
P2093
Alexandra Kaider
Christine Marosi
Christoph Zielinski
Johannes A Hainfellner
Johannes Thaler
P304
P356
10.1016/J.THROMRES.2012.09.020
P577
2012-10-17T00:00:00Z